ebiomedicine

[1] Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.

[2] a case report of renal ewing sarcoma

[3] primary ewing sarcoma of the thyroid—eight cases in a decade: a case report and literature review

[4] a comparison of pediatric vs. adult patients with the ewing sarcoma family of tumors

[5] Gene expression and immunohistochemical analyses identify SOX2 as major risk factor for overall survival and relapse in Ewing sarcoma patients.

[6] a case report of renal ewing sarcoma

[7] ewing sarcoma of the posterior fossa in an adolescent girl

[8] ecteinascidin 743 interferes with the activity of ews-fli1 in ewing sarcoma cells

[9] primary ewing sarcoma of the thyroid—eight cases in a decade: a case report and literature review

[10] a comparison of pediatric vs. adult patients with the ewing sarcoma family of tumors

[11] expression of cathepsin l in tumor cells and tumor-associated macrophages in patients with ewing sarcoma family of tumors: a pilot study

[12] Histone Methyltransferases G9a/<i>Ehmt2</i> and GLP/<i>Ehmt1</i> Are Associated with Cell Viability and Poorer Prognosis in Neuroblastoma and Ewing Sarcoma